Prevalence and clinical relevance of negative histology after transsphenoidal surgery for pituitary neuroendocrine tumors
Frontiers in Endocrinology · 2026
DOI: 10.3389/fendo.2026.1933467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2026. Verfasst von Gilles De Cannière und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Université Catholique de Louvain, Brussels, Belgium. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Neuroendocrine Tumors. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Negative histology (NH), defined as normal pituitary tissue without histopathological evidence of tumor despite clinical, biochemical and radiological or functional evidence of a pituitary neuroendocrine tumor (PitNET), is well described in Cushing’s disease but poorly characterized in other subtypes. We assessed its prevalence, mechanisms, and clinical implications.
Methods
We retrospectively analyzed 651 patients who underwent transsphenoidal surgery for a PitNET (1996–2023). Epidemiological analyses included the entire cohort; clinical and prognostic analyses were restricted to microadenomas of the three main functional subtypes (ACTH, PRL, GH).
Results
NH occurred in 28.1% of ACTH-, 28.1% of PRL-, and 11.4% of GH-secreting tumors, and was strongly associated with microadenomas. Baseline and hormonal characteristics were similar between NH and PH cases, except for lower IGF-1 levels in GH NH tumors. At 6 weeks, remission rates were lower in NH for ACTH (60% vs. 93.2%, p < 0.01) and PRL (50% vs. 79.3%, p = 0.03), but similar in GH. In ACTH tumors, mislocalization accounted for 66.7% of unfavorable NH outcomes and may explain the excess of failures versus PH cases. Mislocalization was rare (6.7%) in PRL tumors and not reported in GH tumors.
Conclusion
NH is heterogeneous, arising from three mechanisms whose contributions vary by subtype. In ACTH tumors, mislocalization predominates and is associated with lower early remission. In PRL tumors, mislocalization is uncommon but may contribute to lower early remission. In GH tumors, NH likely reflects technical or histological limitations and carries a favorable prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Université Catholique de Louvain, Brussels, Belgium.
- Department of Neurosurgery, Saint-Luc University Hospital, Brussels, Belgium.
- Department of Neurosurgery, Clinique Notre-Dame de Grace (CNDG), Gosselies, Belgium.
- Department of Pathology, Saint-Luc University Hospital, Brussels, Belgium.
- Department of Endocrinology and Nutrition, Saint-Luc University Hospital, Brussels, Belgium.
Zitieren
APA
De Cannière, G., Raftopoulos, C., Maiter, D., de Nijs, L., Daoud, L., Constantinescu, S. M., Alexopoulou, O., & Fomekong, E. (2026). Prevalence and clinical relevance of negative histology after transsphenoidal surgery for pituitary neuroendocrine tumors. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1933467
Vancouver
De Cannière G, Raftopoulos C, Maiter D, de Nijs L, Daoud L, Constantinescu SM, et al. Prevalence and clinical relevance of negative histology after transsphenoidal surgery for pituitary neuroendocrine tumors. Frontiers in Endocrinology. 2026. doi:10.3389/fendo.2026.1933467
BibTeX
@article{DeCannire2026,
author = {De Cannière, Gilles and Raftopoulos, Christian and Maiter, Dominique and de Nijs, Loic and Daoud, Lina and Constantinescu, Stefan Matei and Alexopoulou, Orsalia and Fomekong, Edward},
title = {Prevalence and clinical relevance of negative histology after transsphenoidal surgery for pituitary neuroendocrine tumors},
journal = {Frontiers in Endocrinology},
year = {2026},
doi = {10.3389/fendo.2026.1933467}
}
EUVIMED